Latest Strategy Changes News

Page 221 of 935
Cleanaway Waste Management faced a challenging FY25 with multiple fatalities prompting a safety overhaul, yet reported robust financial growth and reaffirmed FY26 guidance. Strategic acquisitions and operational improvements signal a determined path forward.
Maxwell Dee
Maxwell Dee
21 Oct 2025
Cleanaway Waste Management reaffirms its FY26 earnings guidance despite a slow start to the year and unveils plans for an indirect cost reduction program aimed at boosting efficiency.
Maxwell Dee
Maxwell Dee
21 Oct 2025
Yancoal’s September quarter report reveals stable coal output and a slight dip in realised prices, alongside a leadership change and strategic stake increase in the Moolarben Joint Venture.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Connected Minerals reports strong uranium grades from its Etango North-East Project in Namibia and progresses rare earth exploration plans in Western Australia, maintaining a solid financial footing.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Vonex Limited has finalized its Scheme of Arrangement, transferring all shares to Maxo Telecommunications and initiating a board overhaul ahead of its imminent ASX delisting.
Sophie Babbage
Sophie Babbage
20 Oct 2025
Chalice Mining is progressing its Gonneville Project Pre-Feasibility Study on schedule for November 2025 completion, fully funded and targeting a Final Investment Decision by late 2027 as palladium prices hit a two-year high.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Prominence Energy has extended its agreement to acquire the Gawler Hydrogen Project, allowing more time to secure final regulatory approvals and advance exploration in South Australia.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.
Ada Torres
Ada Torres
20 Oct 2025
Actinogen Medical has received approval for an additional $1.87 million research and development tax rebate, bringing its total FY25 rebate to $7.36 million. This funding underpins ongoing clinical trials of its Alzheimer’s and depression therapy candidate, Xanamem.
Ada Torres
Ada Torres
20 Oct 2025
United States Antimony Corporation has made a non-binding indicative offer to acquire Larvotto Resources at a significant premium, proposing a strategic merger focused on antimony supply chain security and growth.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Flynn Gold Limited has reported significant progress in its Tasmanian gold exploration projects, including new high-grade gold discoveries and a successful $5 million capital raise to fund further drilling and development.
Maxwell Dee
Maxwell Dee
20 Oct 2025
Audio Pixels Holdings has extended the maturity of $12.3 million in convertible notes to January 2027 and capitalised $4.05 million in accrued interest, enhancing its financial flexibility.
Sophie Babbage
Sophie Babbage
20 Oct 2025